Trials / Completed
CompletedNCT01885065
Efficacy of Novel Edible Gel-based Artificial Saliva in Cancer Patients
Efficacy Study of Novel Edible Gel-based Artificial Saliva in Xerostomic Cancer Patients
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 25 (actual)
- Sponsor
- Dental Innovation Foundation Under Royal Patronage · Academic / Other
- Sex
- All
- Age
- 35 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether continuous use of edible, gel-based artificial saliva in cancer patients with dry mouth problems will reduce signs and symptoms of dry mouth and improve quality of patients' saliva.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Gel-based artificial saliva | Gel-based artificial saliva is an edible non-nutritious gel intended to relieve dry mouth. Taking orally 1-2 teaspoon each time, 5 times / day (30-50 ml/ day) for four weeks. |
Timeline
- Start date
- 2012-07-01
- Primary completion
- 2012-09-01
- Completion
- 2012-12-01
- First posted
- 2013-06-24
- Last updated
- 2013-06-24
Locations
1 site across 1 country: Thailand
Source: ClinicalTrials.gov record NCT01885065. Inclusion in this directory is not an endorsement.